Fujifilm To Apply For COVID-19 Drug Approval
Fujifilm Holdings Corp. said Monday it has completed delayed clinical tests of Avigan, a potential treatment for COVID-19, paving the way for the application of sales and production of the …
Japanese Firm Launches World’s 1st Coronavirus Killer UV Lamp
A major Japanese light equipment maker Ushio Inc. has recently launched an ultraviolet lamp that can kill the coronavirus without harming human health — the first of its kind in …
Fujifilm Affiliate, Novavax Make COVID-19 Vaccine Candidate
Fujifilm Corp said Friday its biotechnology subsidiary and U.S. vaccine maker Novavax Inc have agreed to manufacture bulk drug substance for the latter’s vaccine candidate against the coronavirus disease. The …
Japanese Startup Creates Internet-Connected Face Mask
As face coverings become the norm amid the coronavirus pandemic, Japanese startup Donut Robotics has developed an internet-connected “smart mask” that can transmit messages and translate from Japanese into eight …
Japanese Toilet Industry May See Surge in Demand Globally
Japanese toilet industry may see a surge in demand globally as people all over the world are becoming more health-conscious than before. The Financial Times wrote a detailed about this …
Fujifilm Speeds Up Manufacturing Avigan As a Possible Cure For COVID-19
TOKYO- Fujifilm Holdings Corp said it has expanded manufacturing capacity to”significantly increase” production of its anti-flu drug Avigan that is being tested as a treatment for COVID-19. Fujifilm expects to …
Toyobo Develops Test Kit To Detect Coronavirus Within One Hour
OSAKA- Japanese fiber and biotechnology firm Toyobo Co said Monday it has developed a test kit capable of detecting the new pneumonia-causing coronavirus within 60 minutes. The company’s SARS-CoV-2 Detection …
How A Japanese Company Became A Darling Of The Eyewear Industry?
KANAGAWA “It’s unavoidable that the identity of a person who wears glasses is closely connected to their glasses. After all, those glasses are part of who the person is.” This …